RL
Richard Law Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
22
Avg Return
Past Year
Past Year
25%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
45.5%
Neutral
36.4%
Negative
18.2%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $95 |
4%
upside
| 1 | – |
–
| 3 Mar ‘26 21 hours ago |
|
|
|
Sell
Maintained
| $3 |
38%
downside
| 2 | +4.2% |
0
%
| 2 Mar ‘26 yesterday |
|
|
|
Neutral
Maintained
| $34 |
17%
upside
| 2 | – |
–
| 2 Mar ‘26 yesterday |
|
|
|
Sell
Downgraded
| $10 |
43%
downside
| 2 | -35% |
0
%
| 15 Jan ‘26 1 month ago |
|
|
|
Buy
Upgraded
| $28 |
25%
upside
| 1 | +5.3% |
0
%
| 13 Jan ‘26 1 month ago |
|
|
|
Buy
Upgraded
| $67 |
67%
upside
| 2 | -25% |
0
%
| 12 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $38 |
62%
upside
| 3 | +129% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $135 |
35%
upside
| 1 | -7.2% |
0
%
| 18 Nov ‘25 3 months ago |
|
|
|
Neutral
Maintained
| $29 |
23%
upside
| 2 | – |
–
| 30 Oct ‘25 4 months ago |
|
|
|
Buy
Maintained
| $52 |
82%
upside
| 1 | -21% |
0
%
| 9 Sep ‘25 5 months ago |
|
|
|
Buy
Maintained
| $30 |
2%
upside
| 2 | +57% |
0
%
| 7 Aug ‘25 6 months ago |
|
|
|
Sell
Maintained
| $3 |
47%
downside
| 2 | -21% |
0
%
| 9 May ‘25 9 months ago |
|
|
|
Neutral
Initiated
| $30 |
6%
downside
| 1 | – |
–
| 8 Apr ‘25 10 months ago |
|